Major Study on Chelation Therapy for Heart Disease

EDTA IV Chelation Therapy might become an accepted therapy for heart disease and circulation problems based on the TACT study

Online PR News – 01-November-2012 – Lima, OHIO – Chelation therapy for heart and vascular disease is a controversial alternative therapy that might become proven effective by TACT (the Trial to Assess Chelation Therapy).
TACT is a 7-year study funded by the NIH and carried out by university cardiologists and experienced chelation physicians from around the United States. This randomized, double-blind study compared patients who had previous heart attacks who were treated with medications with or without intravenous chelation therapy. The results of TACT will be presented at the American Heart Association meeting November 4, 2012 in Los Angeles.
For more information on the development of EDTA Chelation Therapy go to